Tag: Senate

Senate

Regulatory/FDA

Califf Confirmation in Jeopardy?

Califf Confirmation in Jeopardy?

Feb. 7, 2022 – Although the nomination of Dr. Robert Califf to return as FDA Commissioner was advanced by the Senate House, Education, Labor, and Pensions (HELP) Committee just weeks ago and it appeared Califf was poised to be confirmed by the full Senate, new opposition to his nomination reportedly has switched at least some […]

Read more

Washington Focus

Biden Plans Include Key Healthcare Appointments, ACA and, Maybe, Drug Pricing

Biden Plans Include Key Healthcare Appointments, ACA and, Maybe, Drug Pricing

Dec. 7, 2020 – President-elect Joe Biden announced on Dec. 7 his plans for filling key public health positions, including nominations for California Attorney General Xavier Becerra to be the next secretary of Health and Human Services and Dr. Rochelle Walensky, currently an infectious disease specialist at Massachusetts General Hospital, to become director of the […]

Read more

Legislative

Senators Push New Bill to Require Drug List Prices in Ads After Regulation Set Aside by Court

Senators Push New Bill to Require Drug List Prices in Ads After Regulation Set Aside by Court

Nov. 11, 2019 – As Congress works to agree on legislation that would rein in drug prices, a bill co-sponsored by Sen. Charles Grassley (R-Iowa) and Sen. Dick Durbin (D-Ill.) – which would require that list prices be included in direct-to-consumer (DTC) television advertisements – may be close to a vote. Grassley and Durbin hoped […]

Read more

Washington Focus

FDA in Line for Major Budget Increase in Federal Budget Deal

FDA in Line for Major Budget Increase in Federal Budget Deal

July 29, 2019 — Last week’s agreement on parameters for the 2020 fiscal year federal budget is good news for the Food and Drug Administration (FDA). The greatest advantage of the deal for the White House, the Democratic leadership of the House, and the Republican leadership in the Senate, of course, is that it would […]

Read more

DTC Advertising

HELP Committee Hears Testimony on Banning DTC Ads

HELP Committee Hears Testimony on Banning DTC Ads

Dec. 14, 2017 – At a drug pricing hearing held this week by the Senate Health, Education, Labor and Pensions Committee, a representative of the National Academies of Sciences told the panel that the cost of drug advertising must be factored into the price of a drug product, and that Congress should act to end […]

Read more

Senate Bill Would Loop Nurse Practitioners and PAs into Sunshine Reporting

Oct. 12, 2015 – A bill introduced in the Senate last week by Sen. Charles Grassley (R-Iowa) and Sen. Richard Blumenthal (D-Conn.) would broaden Sunshine Act Open Payments reporting to nurse practitioners and physician assistants, according to a recent article in Policy and Medicine. “Although Senators Grassley and Blumenthal are true believers, it’s probably premature […]

Read more